The short version of As-needed dosing fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Receptor activation in hypothalamic and limbic circuits is the mechanism most often cited for the observed effects on sexual desire. Signalling through MC4R couples to Gs proteins and raises intracellular cyclic AMP, which in turn modulates dopaminergic tone in reward-related pathways. Because the peptide reaches the central nervous system after subcutaneous administration, peripheral vascular changes are regarded as secondary rather than primary. The precise neural circuits that translate receptor occupancy into behavioural change remain incompletely mapped, and published accounts describe the pathway in general terms rather than as a fully resolved sequence.
Development began with intranasal formulations investigated for erectile dysfunction, but blood pressure elevation limited that route and prompted a switch to subcutaneous delivery. Clinical testing then shifted toward hypoactive sexual desire disorder in premenopausal women, and a subcutaneous product received United States approval in 2019. Later trials examined other populations with mixed results, and questions about effect size, durability and patient selection remain open in the peer-reviewed literature. Research interest continues in parallel with the broader melanocortin field, where several synthetic analogues are studied together.
PT-141 is the research code for bremelanotide, a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone. The molecule belongs to the melanocortin receptor agonist family and shows highest affinity for the MC4 receptor subtype, with weaker activity at MC1, MC3 and MC5. Its structure retains the core His-Phe-Arg-Trp sequence that defines melanocortin recognition, while cyclization and terminal modifications improve metabolic stability relative to the parent hormone. Early work classified the compound as a centrally acting agent rather than a peripherally acting vasodilator, which shaped subsequent development priorities.
Whether the behavioral effect originates centrally, peripherally, or through both remains an active question. Animal experiments using receptor antagonists and site-specific injections point toward hypothalamic melanocortin circuits as a key locus, but translating those findings to humans is not straightforward. Blood pressure changes observed in trials suggest a vascular component that may be peripherally mediated. The relationship between receptor occupancy and reported effect has not been mapped in humans, and no validated biomarker predicts response. This gap makes it difficult to explain individual variability on pharmacological grounds alone.
Bremelanotide acts as an agonist at melanocortin receptors, a family of five G-protein-coupled receptors labeled MC1 through MC5. Binding studies indicate activity at several of these subtypes rather than strict selectivity for one. Signalling proceeds mainly through Gs-mediated activation of adenylyl cyclase, raising intracellular cyclic AMP. The MC4 receptor, expressed in hypothalamic and limbic circuits, is widely regarded as the subtype most relevant to sexual response. Because the molecule is not subtype-selective, effects at other melanocortin receptors are expected and are used to explain some observed side effects.
| Property | Value | Notes |
|---|---|---|
| Research code | PT-141 | Used in early literature before the generic name became common |
| Generic name | Bremelanotide | International nonproprietary name |
| Peptide class | Cyclic heptapeptide | Seven residues joined by a lactam bridge |
| Primary receptor | MC4R | Lower affinity reported at MC1R, MC3R and MC5R |
| Route studied clinically | Subcutaneous injection | Intranasal route was abandoned after pressor effects |
Clinical programmes in this area have relied mainly on randomised, double-blind, placebo-controlled designs in premenopausal women. Primary endpoints usually combine a validated questionnaire covering desire domains with counts of satisfying sexual events and a separate measure of distress. Reported outcomes show statistically significant but modest average improvement over placebo, with wide individual variation. Adverse events such as nausea, flushing, and headache occur frequently and can limit tolerability. Whether short-term trial gains translate into lasting change for most users is an open question.
Evidence outside the studied population is sparse. Trials have concentrated on premenopausal women with a defined diagnosis, and data for postmenopausal women, men, and people taking interacting medications remain limited. Non-prescription use of the peptide for comparable goals is widespread but is not supported by published controlled data. Observed changes in blood pressure have drawn attention to cardiovascular monitoring during use. The literature generally frames the compound as a targeted receptor agonist rather than a general libido enhancer, and basic questions about mechanism and long-term safety are unresolved.
The word frankfurter comes from Frankfurt, Germany, where pork sausages similar to hot dogs originated. These sausages, Frankfurter Würstchen, were known since the 13th century and given to the people on the event of imperial coronations, starting with the coronation of Maximilian II, Holy Roman Emperor, as King. "Wiener" refers to Vienna, Austria (German: Wien), home to a sausage made of a mixture of pork and beef. Johann Georg Lahner, an 18th/19th century butcher from the Franconian city of Coburg, is said to have brought the Frankfurter Würstchen to Vienna, where he added beef to the mixture and simply called it Frankfurter. Nowadays, in German-speaking countries, except Austria, hot dog sausages are called Wiener or Wiener Würstchen (Würstchen means "little sausage"), to differentiate them from the original pork-only mixture from Frankfurt. In Swiss German, it is called Wienerli, while in Austria the terms Frankfurter or Frankfurter Würstel are used.
== Further reading == Alsalim W, Fadel M (July 2003). "Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Oral methionine compared with intravenous N-acetyl cysteine for paracetamol overdose". Emerg Med J. 20 (4): 366–7. doi:10.1136/emj.20.4.366. PMC 1726135. PMID 12835357. van de Straat R, de Vries J, Debets AJ, Vermeulen NP (July 1987). "The mechanism of prevention of paracetamol-induced hepatotoxicity by 3,5-dialkyl substitution. The roles of glutathione depletion and oxidative stress". Biochem. Pharmacol. 36 (13): 2065–70. doi:10.1016/0006-2952(87)90132-8. PMID 3606627.
==== MeSH E05.318.760 – epidemiologic study characteristics ==== MeSH E05.318.760.500 – epidemiologic studies MeSH E05.318.760.500.500 – case-control studies MeSH E05.318.760.500.500.500 – retrospective studies MeSH E05.318.760.500.750 – cohort studies MeSH E05.318.760.500.750.500 – longitudinal studies MeSH E05.318.760.500.750.500.350 – follow-up studies MeSH E05.318.760.500.750.500.650 – prospective studies MeSH E05.318.760.500.875 – cross-sectional studies MeSH E05.318.760.500.950 – seroepidemiologic studies MeSH E05.318.760.500.950.375 – hiv seroprevalence MeSH E05.318.760.535 – clinical trials MeSH E05.318.760.535.200 – clinical trials, phase i MeSH E05.318.760.535.210 – clinical trials, phase ii MeSH E05.318.760.535.220 – clinical trials, phase iii MeSH E05.318.760.535.230 – clinical trials, phase iv MeSH E05.318.760.535.365 – controlled clinical trials MeSH E05.318.760.535.365.500 – randomized controlled trials MeSH E05.318.760.535.500 – multicenter studies MeSH E05.318.760.550 – feasibility studies MeSH E05.318.760.565 – intervention studies MeSH E05.318.760.750 – pilot projects MeSH E05.318.760.875 – sampling studies MeSH E05.318.760.900 – twin studies
=== Intravenous === Vancomycin must be given intravenously for systemic therapy since it is poorly absorbed from the intestine. Vancomycin is a large hydrophilic molecule that partitions poorly across the gastrointestinal mucosa. Due to its short half-life, it is often injected twice daily.
== Activation == All MMPs are synthesized in the latent form (Zymogen). They are secreted as proenzymes and require extracellular activation. They can be activated in vitro by many mechanisms including organomercurials, chaotropic agents, and other proteases.
Sources: en.wikipedia.org
Barker taped his final episode on June 6, 2007, with the show airing twice on June 15; once in Daytime and once on Primetime. On October 15, 2007, Drew Carey took over hosting duties on the show. After his retirement, Barker made three return appearances to The Price is Right. He first appeared on the episode that aired on April 16, 2009, to promote his new autobiography, Priceless Memories. Barker appeared in the Showcase round at the end of the show. Barker made another guest appearance on the show to celebrate his 90th birthday, which aired on December 12, 2013. Barker announced a contestant for the first time ever on the show, along with one showcase. Barker's last appearance was a surprise appearance on April 1, 2015, for an April Fools' Day switch where he took Carey's place at the show's intro. Barker hosted the first bid and pricing game of that day before handing the hosting duties back to Carey; Barker later appeared during the showcase.
== Function == The main purpose of chondronectin is to allow chondrocytes and collagen II substrates to bond together. When bound, if forms a complex structure called an extracellular scaffold, which helps support the surrounding cells because of bioactive molecule diversity, which allows for chondrocytes to be anchored, mechanical forces to be bared, and maintaining physiological homeostasis. In order for chondronectin to be able to assist in binding within this complex as efficiently as possible, they must interact with a cartilage proteoglycan monomer. If there is a inhibitor that prevents synthesis of endogenous proteoglycans, along with beta-xylosides, it fully prevents chondrocytes from attaching via chondronectins. When cartilage cells attach chondronectin help keep the cells positioned close to important collagen and proteoglycan materials within the extracellular matrix. This allows the cells to support the framework by maintaining surrounding cartilage components. Without attachment, chondrocytes become less effective at preserving the tissue around them. Chondronectin keeps the cartilage framework strong enough to handle daily joint pressure. It helps cartilage deal with the stress caused by regular movement and compression. Since joints face constant wear, cell bonds must stay stable to help prevent tissue damage. This protein plays a key role in keeping cartilage durable and properly supported. Studies indicate that weak adhesive interaction inside cartilage matrix can gradually reduce the integrity to cartilage.
Naturally occurring cadmium (48Cd) is composed of 8 isotopes. For two of them, natural radioactivity has been observed, and three others are predicted to possibly decay though this has not been observed; it may be presumed the half-lives are extremely long. The two natural radioactive isotopes are 113Cd (beta decay, half-life 8.04×1015 years) and 116Cd (double beta decay, half-life 2.69×1019 years). The other three are 106Cd, 108Cd (double electron capture), and 114Cd (double beta decay); only lower limits on their decays have been set. Only three isotopes—110Cd, 111Cd, and 112Cd—are theoretically stable. Among the isotopes absent in natural cadmium, the most long-lived are 109Cd with a half-life of 461.3 days, and 115Cd with a half-life of 53.46 hours. All of the remaining radioactive isotopes have half-lives that are less than 7 hours and the majority of these are less than 5 minutes. This element also has 12 known meta states, with the most stable being 113mCd (t1/2 13.9 years), 115mCd (t1/2 44.6 days) and 117mCd (t1/2 3.44 hours). The known isotopes of cadmium range from 95Cd to 132Cd. The primary decay mode before the stable isotope 112Cd is electron capture to isotopes of silver, and after, beta emission to isotopes of indium. A 2021 study has shown at high ionic strengths, cadmium isotope fractionation mainly depends on its complexation with carboxylic sites. At low ionic strengths, nonspecific cadmium binding induced by electrostatic attractions plays a dominant role and promotes cadmium isotope fractionation during complexation.
AI pornography platforms, beyond account creation and social media linking, primarily enable users to generate sexual images through feature selection or text prompting. Users can customize bodies, clothing, and sociodemographic traits, and browse categorized galleries of user‑generated content. Several sites also support short pornographic videos or GIFs and modification tools such as nudifiers, deepfakes, and facemorphing. Some platforms enable fine‑tuning of parameters such as settings, style, or theme, and provide prompt enhancers or suggestions to improve outputs. Users may edit generated images, refine prior prompts, modify others' work, or upload personal material as a basis, with iterative and collaborative content creation. Some websites additionally host interactive "erobots", customizable in real time for appearance, personality, memories, speech, and profession, enabling tailored sexual and non‑sexual interactions. Less common features include VR integration, AI porn games, audio or doodle prompts, and consensual replication of individuals with verification.
Sources: en.wikipedia.org
The degradation of glycerol by some strains of LAB can yield the compound acrolein. Glycerol is a sweet-tasting polyol present in all wines, but at higher levels in wines that have been infected with Botrytis cinerea. An "active-aldehyde", acrolein can interact with some phenolic compounds in wine to create highly bitter-tasting wines, described as amertume by Pasteur. While at least one strain of O. oeni has been shown to produce acrolein, it is more commonly found in wines that have been infected by strains of Lactobacillus and Pediococcus species such as L. brevis, L. buchneri, and P. parvulus. Acrolein taint has also shown to be more common in wines that have been fermented at high temperatures and/or made from grapes that have been harvested at high Brix levels. Heterofermenting species from the genus Lactobacillus, as well as some wild strains of O. oeni, have the potential to metabolize fructose (one of the main sugars in wine) into the sugar alcohols mannitol and (less commonly) erythritol. These are sweet-tasting compounds can add sweetness to a wine where it is not desired (such as Cabernet Sauvignon). Mannitol taint, described as mannite by Pasteur, in wines is often accompanied by other wine faults, including the presence of excessive levels of acetic acid, diacetyl, lactic acid, and 2-butanol, which can contribute to a "vinegary-estery" aroma. The wine may also have a slimy sheen on the surface.
At the very end of the 19th century, the Japanese administration started the forced assimilation of the native Ainu people. Also at this time the Ainu were granted automatic Japanese citizenship. Many Japanese moved onto former Ainu lands, including the Kuril islands. The Ainu were required to adopt Japanese names. Although not compulsory, education was conducted in Japanese. Prior to Japanese colonization (in 1868) about 100 Ainu reportedly lived on the Kuril islands.
Arabinogalactan-proteins (AGPs) are highly glycosylated proteins (glycoproteins) found in the cell walls of plants. Each one consists of a protein with sugar molecules attached (which can account for more than 90% of the total mass). They are members of the wider class of hydroxyproline (Hyp)-rich cell wall glycoproteins, a large and diverse group of glycosylated wall proteins. AGPs have been reported in a wide range of higher plants in seeds, roots, stems, leaves and inflorescences. AGPs account for only a small portion of the cell wall, usually no more than 1% of dry mass of the primary wall. They have also been reported in secretions of cell culture medium of root, leaf, endosperm and embryo tissues, and some exudate producing cell types such as stylar canal cells are capable of producing lavish amounts of AGPs. They are implicated in various aspects of plant growth and development, including root elongation, somatic embryogenesis, hormone responses, xylem differentiation, pollen tube growth and guidance, programmed cell death, cell expansion, salt tolerance, host-pathogen interactions, and cellular signaling. AGPs have attracted considerable attention due to their highly complex structures and potential roles in signalling. In addition, they have industrial and health applications due to their chemical/physical properties (water-holding, adhesion and emulsification).
Sources: en.wikipedia.org
The code designates bremelanotide, a cyclic heptapeptide melanocortin receptor agonist. It served as an internal research identifier before the compound entered formal clinical development. The code and the generic name refer to the same molecule.
MC4R is generally described as the principal target, based on binding affinity and functional assays. Activity at MC1R, MC3R and MC5R is reported as weaker. Receptor selectivity is one reason the compound was pursued for central rather than vascular effects.
Both are synthetic melanocortin analogues built on a similar cyclic peptide scaffold. Bremelanotide is described in the literature as a metabolite-derived analogue of melanotan II rather than the same substance. The two differ in terminal modifications, which affect half-life and receptor profile.
It is frequently described as an MC4 receptor agonist, but binding assays show activity at more than one melanocortin subtype. Selectivity is therefore relative rather than absolute. This matters when interpreting side effects tied to other receptor subtypes.